Checkpoint Therapeutics Ownership 2024 | Who Owns Checkpoint Therapeutics Now?

Overview Forecast RevenueFinancials Chart

Institutional Ownership

5.63%

Insider Ownership

15.52%

Retail Ownership

78.85%

Institutional Holders

1.00

Checkpoint Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SPOTLIGHT ASSET GROUP, INC.	-	-	-	-661,597	-100.00%	-	Jun 30, 2023

Checkpoint Therapeutics's largest institutional shareholder is SPOTLIGHT ASSET GROUP, INC., holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SPOTLIGHT ASSET GROUP, INC.	-	-	-	-661,597	-100.00%	-	Jun 30, 2023

The largest Checkpoint Therapeutics shareholder by % of total assets is SPOTLIGHT ASSET GROUP, INC.. The company owns 0.00 shares of Checkpoint Therapeutics (CKPT), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SPOTLIGHT ASSET GROUP, INC.	-	-	-	-661,597	-100.00%	-	Jun 30, 2023

As of Jun 30 2023, Checkpoint Therapeutics's largest institutional buyer is SPOTLIGHT ASSET GROUP, INC.. The company purchased -0.66M stocks of CKPT, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SPOTLIGHT ASSET GROUP, INC.	-	-	-	-661,597	-100.00%	-	Jun 30, 2023

As of Jun 30 2023, Checkpoint Therapeutics's biggest institutional seller is SPOTLIGHT ASSET GROUP, INC.. The company sold -0.66M shares of CKPT, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SPOTLIGHT ASSET GROUP, INC.	-	-	-	-661,597	-100.00%	-	Jun 30, 2023

Checkpoint Therapeutics's largest sold out institutional shareholder by shares sold is SPOTLIGHT ASSET GROUP, INC., sold -0.66M shares, valued at -, as of undefined.

Checkpoint Therapeutics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
BlackRock Health Sciences Trust	0.15%	38,420	-	-	Mar 31, 2024
VANGUARD VALLEY FORGE FUNDS	0.02%	10,582	-	-	Mar 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS	0.01%	8,015	-	-	Mar 31, 2024
QUANTITATIVE MASTER SERIES LLC	0.01%	78,344	-	-	Mar 31, 2024
TIAA SEPARATE ACCOUNT VA 1	0.01%	2,817	-	-	Mar 31, 2024
SSGA FUNDS	0.01%	3,383	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.01%	2,838,049	-	-	Mar 31, 2024
ALPS ETF Trust	0.01%	81,098	-	-	Feb 29, 2024
FIDELITY CONCORD STREET TRUST	0.00%	616,544	-	-	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	53,586	-	-	Mar 31, 2024
Calvert Variable Products, Inc.	0.00%	4,373	-	-	Mar 31, 2024
TIAA-CREF LIFE FUNDS	0.00%	2,254	-	-	Mar 31, 2024
Voya VARIABLE PORTFOLIOS INC	0.00%	26,137	-	-	Mar 31, 2024
SCHWAB CAPITAL TRUST	0.00%	33,712	-	-	Feb 29, 2024
SunAmerica Specialty Series	0.00%	372	-	-	Apr 30, 2021
VARIABLE INSURANCE PRODUCTS FUND II	0.00%	3,469	-	-	Mar 31, 2024
Meeder Funds	0.00%	956	-	-	Mar 31, 2024
THRIVENT SERIES FUND INC	0.00%	21,474	-	-	Mar 28, 2024
NORTHERN FUNDS	0.00%	24,916	-	-	Mar 28, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST	0.00%	9,275	-	-	Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	4,269	-	-	Mar 31, 2024
FIDELITY SALEM STREET TRUST	0.00%	407,335	-	-	Mar 31, 2024
ProFunds	0.00%	1,123	-	-	Mar 31, 2024
VALIC Co I	0.00%	24,567	-	-	Feb 29, 2024
VANGUARD SCOTTSDALE FUNDS	0.00%	165,192	-	-	Feb 29, 2024
ALLSPRING MASTER TRUST	0.00%	4,304	-	-	Feb 29, 2024
TIAA-CREF FUNDS	0.00%	199,997	-	-	Mar 31, 2024
NATIONWIDE VARIABLE INSURANCE TRUST	0.00%	8,467	-	-	Mar 31, 2024
NATIONWIDE MUTUAL FUNDS	0.00%	6,979	-	-	Jan 31, 2024
COLLEGE RETIREMENT EQUITIES FUND	0.00%	45,111	-	-	Mar 31, 2024
PENN SERIES FUNDS INC	0.00%	1,100	-	-	Mar 28, 2024
USAA MUTUAL FUNDS TRUST	0.00%	8,346	-	-	Jan 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II	0.00%	346	-	-	Mar 31, 2024
MORGAN STANLEY PATHWAY FUNDS	0.00%	2,484	-	-	Feb 29, 2024
T. Rowe Price Index Trust, Inc.	0.00%	448	-	-	Feb 29, 2024
HC CAPITAL TRUST	0.00%	558	-	-	Mar 31, 2024
SUNAMERICA SERIES TRUST	0.00%	5,598	-	-	Mar 31, 2024
VANGUARD WELLINGTON FUND	0.00%	6,071	-	-	Feb 29, 2024
iSHARES TRUST	0.00%	222,489	-	-	Mar 31, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST	0.00%	31,700	-	-	Mar 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	11,400	-	-	Jan 31, 2024
EQ ADVISORS TRUST	0.00%	12,547	-	-	Mar 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	1,974	-	-	Jan 31, 2024
MASSMUTUAL SELECT FUNDS	0.00%	6,574	-	-	Dec 31, 2023
Dimensional ETF Trust	0.00%	2,541	-	-	Jan 31, 2024
PACIFIC SELECT FUND	0.00%	19,192	-	-	Mar 31, 2024
Bridge Builder Trust	0.00%	21,080	-	-	Mar 31, 2024
Blackstone Alternative Investment Funds	0.00%	200	-	-	Mar 31, 2023
PRINCIPAL FUNDS, INC.	0.00%	10,514	-	-	Feb 29, 2024
BlackRock Variable Series Funds, Inc.	0.00%	5,816	-	-	Mar 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	2,432	-	-	Mar 31, 2024
John Hancock Funds II	0.00%	9,674	-	-	Feb 29, 2024
BLACKROCK FUNDS	0.00%	3,452	-	-	Mar 28, 2024
Advisors' Inner Circle Fund III	0.00%	31	-	-	Jan 31, 2024
SEI INSTITUTIONAL INVESTMENTS TRUST	0.00%	5,900	-	-	Feb 29, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	395	152	62.55%	Mar 31, 2024

Checkpoint Therapeutics's largest mutual fund holder by % of total assets is "BlackRock Health Sciences Trust", owning 38.42K shares, compromising 0.15% of its total assets.

Checkpoint Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Mar, 23	1	-
30 Sep, 22	58	-4.92%
30 Jun, 22	61	-15.28%
31 Mar, 22	72	7.46%
31 Dec, 21	67	-1.47%
30 Sep, 21	68	-6.85%
30 Jun, 21	73	4.29%
31 Mar, 21	70	14.75%
31 Dec, 20	61	19.61%
30 Sep, 20	51	15.91%
30 Jun, 20	44	7.32%
31 Mar, 20	41	13.89%
31 Dec, 19	36	-2.70%
30 Sep, 19	37	-7.50%
30 Jun, 19	40	81.82%
31 Mar, 19	22	15.79%
31 Dec, 18	19	26.67%
30 Sep, 18	15	50.00%
30 Jun, 18	10	-9.09%
31 Mar, 18	11	266.67%
31 Dec, 17	3	50.00%
30 Sep, 17	2	-
30 Jun, 17	2	-

As of 31 Mar 23, 1 institutions are holding Checkpoint Therapeutics's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Mar, 23	661,597	-
30 Sep, 22	11,394,323	14.27%
30 Jun, 22	9,971,262	-22.59%
31 Mar, 22	12,880,862	19.42%
31 Dec, 21	10,785,821	1.98%
30 Sep, 21	10,576,115	-3.91%
30 Jun, 21	11,006,711	-32.06%
31 Mar, 21	16,201,429	42.10%
31 Dec, 20	11,401,720	12.10%
30 Sep, 20	10,171,111	46.08%
30 Jun, 20	6,962,858	23.15%
31 Mar, 20	5,653,822	3.06%
31 Dec, 19	5,486,093	0.08%
30 Sep, 19	5,481,824	-1.57%
30 Jun, 19	5,569,342	78.00%
31 Mar, 19	3,128,786	3.48%
31 Dec, 18	3,023,477	-5.26%
30 Sep, 18	3,191,260	378.61%
30 Jun, 18	666,774	41.51%
31 Mar, 18	471,180	161.49%
31 Dec, 17	180,193	58.66%
30 Sep, 17	113,570	-4.69%
30 Jun, 17	119,160	-

Checkpoint Therapeutics (CKPT) has 661.60K shares outstanding as of 31 Mar 23, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Mar, 23	5.63%	-
30 Sep, 22	12.87%	9.91%
30 Jun, 22	11.39%	4.97%
31 Mar, 22	15.15%	8.03%
31 Dec, 21	13.73%	7.57%
30 Sep, 21	13.47%	6.34%
30 Jun, 21	14.58%	2.75%
31 Mar, 21	23.05%	5.53%
31 Dec, 20	20.42%	6.28%
30 Sep, 20	18.03%	9.98%
30 Jun, 20	13.44%	10.88%
31 Mar, 20	11.11%	4.60%
31 Dec, 19	15.54%	6.18%
30 Sep, 19	15.86%	5.47%
30 Jun, 19	17.03%	18.09%
31 Mar, 19	9.70%	8.65%
31 Dec, 18	10.59%	8.90%
30 Sep, 18	10.91%	207.03%
30 Jun, 18	2.30%	63.35%
31 Mar, 18	1.90%	299.97%
31 Dec, 17	0.80%	321.10%
30 Sep, 17	0.50%	181.27%
30 Jun, 17	0.52%	-

As of 31 Mar 23, Checkpoint Therapeutics is held by 5.63% institutional shareholders, representing a 0.00% growth compared to 30 Sep 22.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Mar, 23	1	-
30 Sep, 22	16	-5.88%
30 Jun, 22	17	-55.26%
31 Mar, 22	38	31.03%
31 Dec, 21	29	-14.71%
30 Sep, 21	34	-5.56%
30 Jun, 21	36	-16.28%
31 Mar, 21	43	-6.52%
31 Dec, 20	46	53.33%
30 Sep, 20	30	7.14%
30 Jun, 20	28	16.67%
31 Mar, 20	24	20.00%
31 Dec, 19	20	-
30 Sep, 19	20	-41.18%
30 Jun, 19	34	183.33%
31 Mar, 19	12	9.09%
31 Dec, 18	11	-
30 Sep, 18	11	57.14%
30 Jun, 18	7	-12.50%
31 Mar, 18	8	300.00%
31 Dec, 17	2	-
30 Sep, 17	-	-100.00%
30 Jun, 17	2	-

1 institutional shareholders have increased their position in CKPT stock as of 31 Mar 23 compared to 16 in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Mar, 23	-	-
30 Sep, 22	13	-23.53%
30 Jun, 22	17	21.43%
31 Mar, 22	14	-12.50%
31 Dec, 21	16	6.67%
30 Sep, 21	15	-21.05%
30 Jun, 21	19	11.76%
31 Mar, 21	17	142.86%
31 Dec, 20	7	-36.36%
30 Sep, 20	11	83.33%
30 Jun, 20	6	-25.00%
31 Mar, 20	8	14.29%
31 Dec, 19	7	-22.22%
30 Sep, 19	9	80.00%
30 Jun, 19	5	25.00%
31 Mar, 19	4	-20.00%
31 Dec, 18	5	66.67%
30 Sep, 18	3	200.00%
30 Jun, 18	1	-
31 Mar, 18	1	-
31 Dec, 17	-	-100.00%
30 Sep, 17	2	-
30 Jun, 17	-	-

- institutional shareholders have reduced their position in CKPT stock as of 31 Mar 23 compared to 13 in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Mar, 23	1	-	661,597	-	5.63%	-	1	-	-	-
30 Sep, 22	58	-4.92%	11,394,323	14.27%	12.87%	9.91%	16	-5.88%	13	-23.53%
30 Jun, 22	61	-15.28%	9,971,262	-22.59%	11.39%	4.97%	17	-55.26%	17	21.43%
31 Mar, 22	72	7.46%	12,880,862	19.42%	15.15%	8.03%	38	31.03%	14	-12.50%
31 Dec, 21	67	-1.47%	10,785,821	1.98%	13.73%	7.57%	29	-14.71%	16	6.67%
30 Sep, 21	68	-6.85%	10,576,115	-3.91%	13.47%	6.34%	34	-5.56%	15	-21.05%
30 Jun, 21	73	4.29%	11,006,711	-32.06%	14.58%	2.75%	36	-16.28%	19	11.76%
31 Mar, 21	70	14.75%	16,201,429	42.10%	23.05%	5.53%	43	-6.52%	17	142.86%
31 Dec, 20	61	19.61%	11,401,720	12.10%	20.42%	6.28%	46	53.33%	7	-36.36%
30 Sep, 20	51	15.91%	10,171,111	46.08%	18.03%	9.98%	30	7.14%	11	83.33%
30 Jun, 20	44	7.32%	6,962,858	23.15%	13.44%	10.88%	28	16.67%	6	-25.00%
31 Mar, 20	41	13.89%	5,653,822	3.06%	11.11%	4.60%	24	20.00%	8	14.29%
31 Dec, 19	36	-2.70%	5,486,093	0.08%	15.54%	6.18%	20	-	7	-22.22%
30 Sep, 19	37	-7.50%	5,481,824	-1.57%	15.86%	5.47%	20	-41.18%	9	80.00%
30 Jun, 19	40	81.82%	5,569,342	78.00%	17.03%	18.09%	34	183.33%	5	25.00%
31 Mar, 19	22	15.79%	3,128,786	3.48%	9.70%	8.65%	12	9.09%	4	-20.00%
31 Dec, 18	19	26.67%	3,023,477	-5.26%	10.59%	8.90%	11	-	5	66.67%
30 Sep, 18	15	50.00%	3,191,260	378.61%	10.91%	207.03%	11	57.14%	3	200.00%
30 Jun, 18	10	-9.09%	666,774	41.51%	2.30%	63.35%	7	-12.50%	1	-
31 Mar, 18	11	266.67%	471,180	161.49%	1.90%	299.97%	8	300.00%	1	-
31 Dec, 17	3	50.00%	180,193	58.66%	0.80%	321.10%	2	-	-	-100.00%
30 Sep, 17	2	-	113,570	-4.69%	0.50%	181.27%	-	-100.00%	2	-
30 Jun, 17	2	-	119,160	-	0.52%	-	2	-	-	-

Checkpoint Therapeutics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Jun 28, 2024	Oliviero James F III	director, officer	CEO, President and Director	S-Sale	Sell	24,610	$2.05	$50.45K	1,977,170
Jun 28, 2024	GRAY WILLIAM GARRETT	officer	Chief Financial Officer	S-Sale	Sell	13,038	$2.06	$26.86K	672,186

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jun 28, 2024	Oliviero James F III	director, officer	CEO, President and Director	S-Sale	Sell	24,610	$2.05	$50.45K	1,977,170
Jun 28, 2024	Oliviero James F III	director, officer	CEO, President and Director	G-Gift	Sell	37,890	-	-	1,939,280
Jun 28, 2024	GRAY WILLIAM GARRETT	officer	Chief Financial Officer	S-Sale	Sell	13,038	$2.06	$26.86K	672,186
May 24, 2024	Fortress Biotech, Inc.	10 percent owner	-		Sell	-	-	-	3,589,193
May 24, 2024	Fortress Biotech, Inc.	10 percent owner	-		Sell	700,000	-	-	-
Mar 19, 2024	Amit Sharma	director	-		Sell	-	-	-	50,000

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jun 28, 2024	Oliviero James F III	director, officer	CEO, President and Director	S-Sale	Sell	24,610	$2.05	$50.45K	1,977,170
Jun 28, 2024	Oliviero James F III	director, officer	CEO, President and Director	G-Gift	Sell	37,890	-	-	1,939,280
Jun 28, 2024	GRAY WILLIAM GARRETT	officer	Chief Financial Officer	S-Sale	Sell	13,038	$2.06	$26.86K	672,186
May 24, 2024	GRAY WILLIAM GARRETT	officer	Chief Financial Officer	A-Award	Buy	540,000	-	-	685,224
May 24, 2024	Oliviero James F III	director, officer	CEO, President and Director	A-Award	Buy	1,660,000	-	-	2,001,780
May 24, 2024	Fortress Biotech, Inc.	10 percent owner	-		Sell	-	-	-	3,589,193
May 24, 2024	Fortress Biotech, Inc.	10 percent owner	-		Sell	700,000	-	-	-
May 16, 2024	WEISS MICHAEL S	director	-	A-Award	Buy	50,000	-	-	112,174
May 16, 2024	WEISS MICHAEL S	director	-	A-Award	Buy	32,051	-	-	62,174
May 16, 2024	Amit Sharma	director	-	A-Award	Buy	32,051	-	-	82,051
May 16, 2024	SALZMAN BARRY M	director	-	A-Award	Buy	50,000	-	-	117,174
May 16, 2024	SALZMAN BARRY M	director	-	A-Award	Buy	32,051	-	-	67,174
May 16, 2024	ROSENWALD LINDSAY A MD	director	-	A-Award	Buy	50,000	-	-	132,174
May 16, 2024	ROSENWALD LINDSAY A MD	director	-	A-Award	Buy	32,051	-	-	82,174
May 16, 2024	Herskowitz Neil	director	-	A-Award	Buy	50,000	-	-	117,174
May 16, 2024	Herskowitz Neil	director	-	A-Award	Buy	32,051	-	-	67,174
May 16, 2024	Bechon Christian	director	-	A-Award	Buy	50,000	-	-	114,529
May 16, 2024	Bechon Christian	director	-	A-Award	Buy	32,051	-	-	64,529
Mar 22, 2024	Fortress Biotech, Inc.	10 percent owner	-	A-Award	Buy	193,905	-	-	2,096,278
Mar 19, 2024	Amit Sharma	director	-		Sell	-	-	-	50,000

The last insider sell of Checkpoint Therapeutics's stock was made by Oliviero James F III on Jun 28 2024, selling 24,610 shares at $2.05 per share (valued at $50.45K).

Checkpoint Therapeutics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	13	5	260.00%
Q1 2024	1	7	14.29%
Q4 2023	1	-	-
Q3 2023	1	-	-
Q2 2023	8	-	-
Q1 2023	6	8	75.00%
Q4 2022	-	-	-
Q2 2022	6	7	85.71%
Q1 2022	2	7	28.57%
Q2 2021	6	-	-
Q1 2021	2	3	66.67%
Q4 2020	-	1	-
Q2 2020	6	1	600.00%
Q1 2020	2	-	-
Q4 2019	1	-	-
Q2 2019	6	-	-
Q1 2019	2	-	-
Q4 2018	3	1	300.00%
Q2 2018	5	-	-
Q1 2018	2	-	-

13 total buy trades, and 5 total sell trades (buy/sell ratio of 2.60%) were made by Checkpoint Therapeutics's insiders, as of Q2 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	-	2	-
Q1 2024	-	4	-
Q4 2023	-	-	-
Q3 2023	-	-	-
Q2 2023	-	-	-
Q1 2023	-	8	-
Q4 2022	-	-	-
Q2 2022	-	7	-
Q1 2022	-	2	-
Q2 2021	-	-	-
Q1 2021	-	3	-
Q4 2020	-	1	-
Q2 2020	-	1	-
Q1 2020	-	-	-
Q4 2019	1	-	-
Q2 2019	-	-	-
Q1 2019	-	-	-
Q4 2018	3	-	-
Q2 2018	-	-	-
Q1 2018	-	-	-

As of Q2 2024, Insider owners conducted 0 open market buy trades and 2 open market sell trades of Checkpoint Therapeutics's stocks.

Checkpoint Therapeutics Peer Ownership

Ticker	Company
CUE	Cue Biopharma, Inc.
ACHL	Achilles Therapeutics plc
RVPH	Reviva Pharmaceuticals Holdings, Inc.
CTMX	CytomX Therapeutics, Inc.
SPRO	Spero Therapeutics, Inc.
FBIO	Fortress Biotech, Inc.
MDNA	Medicenna Therapeutics Corp.
KOD	Kodiak Sciences Inc.
ASMB	Assembly Biosciences, Inc.
MBIO	Mustang Bio, Inc.
PIRS	Pieris Pharmaceuticals, Inc.
ATXI	Avenue Therapeutics, Inc.
NLTX	Neurogene Inc.
ALRN	Aileron Therapeutics, Inc.
TIL	Instil Bio, Inc.
LUMO	Lumos Pharma, Inc.

CKPT Ownership FAQ

Who Owns Checkpoint Therapeutics?

Checkpoint Therapeutics is owned by institutional shareholders (5.63%), insiders (15.52%), and public (78.85%). The largest institutional shareholder of Checkpoint Therapeutics is SPOTLIGHT ASSET GROUP, INC. (0% of total shares) and the top mutual fund owner is BlackRock Health Sciences Trust (0.15% of total shares).

Who are the major institutional shareholders of Checkpoint Therapeutics?

Checkpoint Therapeutics's major institutional shareholders are SPOTLIGHT ASSET GROUP, INC.. The top five shareholders own together 0% of the company's share outstanding.

How many Checkpoint Therapeutics shareholders are there?

As of Mar 2023, there are 1 institutional shareholders of Checkpoint Therapeutics.

What percentage of Checkpoint Therapeutics is owned by SPOTLIGHT ASSET GROUP, INC?

SPOTLIGHT ASSET GROUP, INC owns 0 shares of Checkpoint Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2023).